# Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)

Study · id `cardio:ct-nct07083154` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07083154](<https://clinicaltrials.gov/study/NCT07083154>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07083154

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 420 participants.

## Technical summary

Registry record NCT07083154. Randomized; quadruple masking; primary purpose treatment. Start 2025-09-27 (actual); primary completion 2029-08-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 420 participants (planned count; ClinicalTrials.gov record NCT07083154, source copy `cardio:ctgov-nct07083154-2026-09-02`, retrieved 2026-10-26)
- Started: 2025-09-27 (actual) (ClinicalTrials.gov record NCT07083154, source copy `cardio:ctgov-nct07083154-2026-09-02`, retrieved 2026-10-26)
- Primary completion: 2029-08-01 (anticipated) (ClinicalTrials.gov record NCT07083154, source copy `cardio:ctgov-nct07083154-2026-09-02`, retrieved 2026-10-26)
- Completion: 2029-08-01 (anticipated) (ClinicalTrials.gov record NCT07083154, source copy `cardio:ctgov-nct07083154-2026-09-02`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07083154, source copy `cardio:ctgov-nct07083154-2026-09-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07083154-2026-09-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)
- Condition: Dementia, Mild
- Condition: Mild Cognitive Impairment
- Condition: Type 2 Diabetes
- Intervention (Drug): Mazdutide
- Intervention (Drug): Placebo
- Lead sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Lead sponsor class: OTHER
- Collaborator: Nanjing First Hospital, Nanjing Medical University
- Collaborator class: OTHER
- Collaborator: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Collaborator class: OTHER
- Collaborator: Xiangya Hospital of Central South University
- Collaborator class: OTHER
- Collaborator: Huadong Hospital
- Collaborator class: OTHER
- Collaborator: Jiangsu Province Hospital of Traditional Chinese Medicine
- Collaborator class: OTHER
- Collaborator: Changzhou No.2 People's Hospital
- Collaborator class: OTHER
- Collaborator: The Second Affiliated Hospital of Dalian Medical University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (`cardio:org-the-affiliated-nanjing-drum-tower-hospital-of-nanjing-3a906f`)
- Registry lists this organization as a collaborator: Nanjing First Hospital, Nanjing Medical University (`cardio:org-nanjing-first-hospital-nanjing-medical-university`)
- Registry lists this organization as a collaborator: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (`cardio:org-shanghai-general-hospital-shanghai-jiao-tong-university-237209`)
- Registry lists this organization as a collaborator: Xiangya Hospital of Central South University (`cardio:org-xiangya-hospital-of-central-south-university`)
- Registry lists this organization as a collaborator: Jiangsu Province Hospital of Traditional Chinese Medicine (`cardio:org-jiangsu-province-hospital-of-traditional-chinese-medicine`)
- Registry lists this organization as a collaborator: The Second Affiliated Hospital of Dalian Medical University (`cardio:org-the-second-affiliated-hospital-of-dalian-medical-university`)

## Provenance

Content hash: 0c83b8f3da0041e562ec999effaa02aa726edade36c808f2ef7a9cb953dd270a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
